News LUMIBIRD

Equities

Real-time Euronext Paris Other stock markets 04:46:30 2024-05-07 am EDT			5-day change	1st Jan Change
13 ^EUR	+0.78%		+4.42%	+6.73%

May. 03	Lumibird launches product for dry eyes	CF
Apr. 23	Lumibird: over 7% growth in quarterly sales	CF

Lumibird launches product for dry eyes	May. 03	CF
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	GL
LUMIBIRD MEDICAL OBTAINS CE MARKING FOR C.DIAG®, A PLATFORM TO HELP DIAGNOSE DRY EYE	May. 03	AQ
Lumibird: over 7% growth in quarterly sales	Apr. 23	CF
LUMIBIRD: PUBLICATION OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE ANNUAL FINANCIAL REPORT	Apr. 05	GL
LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2024	Mar. 25	GL
Lumibird: EBITDA improved by 10% in 2023	Mar. 13	CF
LUMIBIRD: ANNUAL RESULTS 2023	Mar. 12	GL
Lumibird SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
LUMIBIRD : nombre d'actions au 29 février 2024	Mar. 07	PU
Lumibird: two orders from Saab for OdiPro	Mar. 01	CF
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90	Feb. 29	GL
Lumibird: the stock outperforms after a positive note	Feb. 19	CF
Lumibird: sales up by almost 7% in 2023	Jan. 30	CF
LUMIBIRD: 2023 REVENUES AT €203.6M	Jan. 29	GL
The LUMIBIRD Group Reports Unaudited Consolidated Sales Results for the Fourth Quarter and Full Year Ended 31 December 2023	Jan. 29	CI
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	GL
LUMIBIRD: FINANCIAL COMMUNICATIONS AGENDA	Jan. 26	AQ
Lumibird: heavy decline after target adjustment	Dec. 15	CF
LUMIBIRD ADJUSTS ITS 2023 GROWTH TARGET	Dec. 14	GL

No results for this search